HealthMatch is a digital health company founded in 2017 and headquartered in Australia, with a focus on the Biotechnology, Health Care, and Pharmaceutical industries. The company's slogan, "Connecting People To Revolutionary Drugs And Potential Cures," encapsulates its mission to transform the way patients connect to clinical trials.
HealthMatch's platform utilizes machine learning and artificial intelligence to allow patients to find clinical trials tailored to their medical profile in the fastest and simplest way possible. This real-time matching system aims to dramatically accelerate patient recruitment and progress life-saving cures onto the market faster than existing practices allow.
The company recently secured a $10.00M Series C investment on 12 September 2022, with Square Peg Capital and Folklore Ventures as the lead investors. This significant investment reflects the confidence of these notable investors in HealthMatch's innovative approach and its potential to make a substantial impact in the healthcare and pharmaceutical sectors.
No recent news or press coverage available for HealthMatch .